SELLAS Life Sciences Group, Inc. (SLS)

NASDAQ: SLS · Real-Time Price · USD

13.34

+0.13 (0.98%)

At close: Aug 31, 2026, 4:00 PM EDT

13.28

-0.06 (-0.45%)

Pre-market: Sep 1, 2026, 4:44 AM EDT

SLS Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	138.34	71.79	13.89	2.53	17.13	21.36
Cash & Short-Term Investments	138.34	71.79	13.89	2.53	17.13	21.36
Cash Growth	446.88%	417.02%	448.85%	-85.23%	-19.81%	-39.51%
Prepaid Expenses	0.94	0.19	0.17	0.14	0.3	0.25
Restricted Cash	0.1	0.1	0.1	0.1	0.1	0.1
Other Current Assets	3.12	3.12	2.17	0.4	0.23	1.34
Total Current Assets	142.51	75.21	16.33	3.17	17.76	23.04
Property, Plant & Equipment	0.71	0.96	0.93	0.86	0.87	0.72
Goodwill	1.91	1.91	1.91	1.91	1.91	1.91
Other Long-Term Assets	0.25	0.26	0.27	0.28	0.4	0.59
Total Assets	145.38	78.35	19.43	6.22	20.94	26.28

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	3.09	2.95	3.5	5.64	3.36	2.14
Accrued Expenses	2.83	3.48	5.42	7.61	6.29	2.48
Current Portion of Leases	0.58	0.54	0.54	0.45	0.37	0.2
Other Current Liabilities	1.08	0.04	0.04	0.04	5.5	0.16
Total Current Liabilities	7.57	7.02	9.51	13.74	15.52	4.98
Long-Term Leases	0.16	0.46	0.46	0.46	0.57	0.61
Other Long-Term Liabilities	-	-	-	-	0	0.34
Total Liabilities	7.73	7.47	9.97	14.2	16.09	5.93

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.02	0.02	0.01	0	0	0
Additional Paid-In Capital	430.64	345.84	257.58	209.27	184.75	158.95
Retained Earnings	-293	-274.99	-248.13	-217.24	-179.9	-138.6
Shareholders' Equity	137.66	70.87	9.47	-7.98	4.85	20.35
Total Liabilities & Equity	145.38	78.35	19.43	6.22	20.94	26.28

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.74	1	1	0.91	0.95	0.81
Net Cash (Debt)	137.61	70.79	12.89	1.62	16.18	20.55
Net Cash Growth	460.29%	449.41%	693.41%	-89.96%	-21.25%	-40.12%
Net Cash Per Share	0.90	0.65	0.21	0.06	0.83	1.33
Filing Date Shares Outstanding	201.95	179.58	90.85	56.27	28.3	15.91
Total Common Shares Outstanding	201.92	153.1	73.98	32.13	21.01	15.9
Working Capital	134.94	68.19	6.82	-10.56	2.24	18.06
Book Value Per Share	0.68	0.46	0.13	-0.25	0.23	1.28
Tangible Book Value	135.74	68.96	7.55	-9.89	2.94	18.43
Tangible Book Value Per Share	0.67	0.45	0.10	-0.31	0.14	1.16

SEC Filings: 10-K · 10-Q